Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin i and brain natriuretic peptide

International Journal of Cardiology

Volumn 148, Issue 2, 2011, Pages 194-198

  Feola, Mauro ^a   Garrone, Ornella ^b   Occelli, Marcella ^b   Francini, Antonella ^b   Biggi, Alberto ^b   Visconti, Gianluca ^b   Albrile, Fabrizia ^b   Bobbio, Marco ^c   Merlano, Marco ^b  

^a Ospedale 4   (Italy)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c Department Cardiovascular Disease Ospedale Santa Croce Carle Cuneo ^*  (Italy)

Author keywords

Antracycline cardiotoxicity; Brain natriuretic peptide; Chemotherapy; Radioisotopic ventriculography

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; TROPONIN I;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CARDIOTOXICITY; CLINICAL ASSESSMENT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOISOTOPE VENTRICULOGRAPHY; SIDE EFFECT; SYSTOLIC DYSFUNCTION;

ADULT; AGED; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEMALE; FLUOROURACIL; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; STROKE VOLUME; TROPONIN I; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79953254791     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.09.564     Document Type: Article

References (32)

1. Effect of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Lancet 365 2005 1687 1717
2. P.K. Singal, and N. Iliskovic Doxorubicin-induced cardiomyopathy N Engl J Med 332 1995 1738 1743
3. D. Von Hoff, M. Layard, and P. Basa Risk factors for doxorubicin-induced congestive heart failure Ann Inter Med 91 1979 710 717 (Pubitemid 10218041)
4. C. Praga, F. Trave, and A. Petroccione Anthracycline-induced cardiotoxicity and its relevance in cancer treatment W.S. Nimmo, G.T. Tucker, Clinical Measurement in Drug Evaluation 1991 CRC Press Boca Raton, FL 131 142
5. W.I. Ganz, K.S. Sridhar, and S.S. Ganz Review of tests for monitoring doxorubicin-induced cardiomyopathy Oncology 53 1996 461 470 (Pubitemid 26388387)
6. I. Mitani, D. Jain, and T.M. Joska Doxurubicin cardiotoxicity: prevention of congestive heart failure with serial function monitoring with equilibrium radionuclide angiocardiography in the current era J Nucl Cardiol 10 2003 132 139 (Pubitemid 36503798)
7. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150
8. J.R. Corbett, O.O. Akinboboye, and S.L. Bacharach Equilibrium radionuclide angiocardiography J Nucl Cardiol 13 2006 e56 e79
9. D. Von Hoff, M. Layard, and P. Basa Risk factor for doxurubicin-induced congestive heart failure Ann Intern Mad 91 1979 710 717 (Pubitemid 10218041)
10. S.M. Swain, F.S. Whaley, and M.S. Ewer Congestive heart failure in patients treated with doxorubicin. A retrospective analysis of three trials Cancer 97 2003 2869 2879 (Pubitemid 36605157)
11. K. Shan, A. Lincoff, and J. Young Anthracycline-induced cardiotoxicity Ann Intern Med 125 1996 45 78
12. J. Wojtacki, E. Lewicka-Nowak, and K. Lesniewsky-Kmak Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention-review of the literature Med Sci Monit 6 2000 411 420 (Pubitemid 30313187)
13. M. Ryberg, D. Nielsen, and T. Skovsgaard Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer J Clin Oncol 16 1998 3502 3508 (Pubitemid 28506760)
14. T.M. Suter, M. Procter, and D.J. van Veldhvisen Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial J Clin Oncol 25 2007 3859 3865 (Pubitemid 47477261)
15. D. Cardinale, M.T. Sandri, and A. Martinoni Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy Ann Oncol 13 2002 710 715 (Pubitemid 34567376)
16. D. Cardinale, M.T. Sandri, and A. Colombo Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy Circulation 109 2004 2749 2754 (Pubitemid 38737923)
17. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167 (Pubitemid 34764819)
18. T.J. Wang, M.G. Larson, and D. Levy Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663 (Pubitemid 38364624)
19. A. Maisel, J.E. Hollander, and D. Guss Primary results of the rapid emergency department heart failure outpatients' trial (REDHOT) J Am Coll Cardiol 44 2004 1328 1333
20. M. Feola, N. Aspromonte, and C. Canali Prognostic value of plasma brain natriuretic peptide, urea nitrogen and creatinine in outpatients > 70 years of age with heart failure Am J Cardiol 96 5 2005 705 709 (Pubitemid 41207318)
21. T.A. McDonagh, S.D. Robb, and D.R. Murdoch Biochemical detection of left-ventricular systolic dysfunction Lancet 351 1998 9 13 (Pubitemid 28020159)
22. T. Nousiainen, E. Vanninen, and E. Jantunen Natriuretic peptides during the development of doxorubicin-induced left ventricular dysfunction J Intern Med 251 2002 228 234 (Pubitemid 34227187)
23. G. Daugaard, U. Lassen, and P. Bie Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular function Eur J Heart Fail 7 2005 87 93 (Pubitemid 40092497)
24. U. Alehagen, J.P. Goetze, and U. Dahlstrom Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt.proBNP) in the elderly Clin Chim Acta 382 2007 8 14 (Pubitemid 46782725)
25. M. Nybo, M. Benn, and R. Mogelvang Impact of haemoglobin on plasma pro-B-type natriuretic peptide concentrations in the general population Clin Chem 53 2007 1921 1927 (Pubitemid 350036036)
26. H. Fukuta, N. Ohte, and S. Mukai Anemia is an independent predictor for elevated plasma level of natriuretic peptides in patients undergoing cardiac catheterization for coronary artery disease Circ J 72 2008 212 217 (Pubitemid 351413358)
27. R. Shah Endothelins in health and disease Eur J Intern Med 18 2007 272 282 (Pubitemid 46898789)
28. T. Suzuki, D. Hayashi, and T. Yamazaki Elevated B-type natriuretic peptide levels after anthracycline administration Am Heart J 136 1998 362 363 (Pubitemid 28368863)
29. F. De Nigris, M. Rienzo, and C. Schiano Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart Eur J Cancer 44 2008 334 340
30. N. Kalay, E. Basar, and I. Ozdogru Protective effects of carvedilol against antthracycline-induced cardiomyopathy J Am Coll Cardiol 48 2006 2258 2262 (Pubitemid 44855419)
31. S. Bien, A. Riad, and C.A. Ritter The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy Cancer Res 67 2007 10428 10435 (Pubitemid 350070818)
32. D. Cardinale, A. Colombo, and M.T. Sandri Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition Circulation 114 2006 2474 2481 (Pubitemid 44901520)